Skip to content
Noroxi
CVE-2019-1932· NVD / CVE Program· CNA cisco

Cisco Advanced Malware Protection for Endpoints Windows Command Injection Vulnerability

Noroxi assessment

Priority: Monitor (action score 26/100)

  • The sources we track (CISA KEV, Exploit-DB, Metasploit, Nuclei, GitHub) show no public exploit code or exploitation in the wild.
  • Probability of exploitation in the next 30 days: 0.26% (FIRST EPSS).
  • Someone with local access to the system can trigger it. Administrator privileges are required. No user action is required. No special conditions are required; it is repeatable.
  • According to the record, no fixed version is available yet.

Low priority for now. Update when a fix is released; follow the vendor's advisory.

Generated automatically from the record's data: CVSS (NVD and CNA), CISA KEV and SSVC, FIRST EPSS, exploit sources, fixed versions. How we calculate it

Primary sources: NVD · CVE.org · FIRST EPSS

A vulnerability in Cisco Advanced Malware Protection (AMP) for Endpoints for Windows could allow an authenticated, local attacker with administrator privileges to execute arbitrary code. The vulnerability is due to insufficient validation of dynamically loaded modules. An attacker could exploit this vulnerability by placing a file in a specific location in the Windows filesystem. A successful exploit could allow the attacker to execute the code with the privileges of the AMP service.

MediumCVSS 6.7 · v3.0—No exploit No fix recorded
Published
Jul 5, 2019
Updated
Jun 16, 2026
EPSS
0.3% · 18th percentile

Report tools

JSON

Action score

26

Monitor

Low priority for now.

CVSS
26 / 40 · 6.7 / 10
CISA KEV
0 / 30 · Not listed
EPSS
0 / 30 · 0.3%

CISA SSVC decision

Exploitation
none
Automatable
no
Technical impact
total

Vulnrichment: CISA's decision-tree inputs.

CNA vs NVD score

NVD
6.7
CNA · cisco
6.7
agree

The score given by the assigning authority versus NVD’s independent score. A gap means the severity is contested.

Get told when this record changes

  • Not in KEV: no record of exploitation in the wild
  • No public exploit code on record
  • No fixed version yet

If any of these changes, we'll tell you in the daily email digest.

Follow CVE-2019-1932

When you'll hear from us

  • when it enters CISA KEV
  • when exploit code appears or is weaponized
  • when the record is updated (including a fixed version)
  • when EPSS rises 20 points in a week

One daily email digest (06:00 UTC); connect a webhook for KEV listings and weaponized exploits instantly.

Your free account also gets you

Running WordPress? Scan your site free with WP Lens

  • Stack alerts: add the products and versions you run, get the new CVEs that affect them
  • Port scanning: 5 full scans a day (members only)
  • Uptime monitoring: 1 site, instant email when it goes down
  • Verify your domain: subdomains and takeover risk scanned every week
  • 10 scans an hour on the security tools (3 a day without an account), an API key and MCP
All free tools

Sign up with email · Have an account? Sign in

Free account, no card. Unfollow any time.

Don't want an account? Get "Exploited this week" by email every MondayDon't want an account? RSS feed for cisco records

Running WordPress? Scan your site free with WP Lens

Is your version affected? Check it

Noroxi analysis

What does it mean in your environment?

The assessment above is generated automatically from the record's data; it doesn't know your environment. Our team verifies on your systems whether this vulnerability is actually exploitable and which mitigation is enough.

We use this product, ask for help

Affected systems

Is your version affected?

Pick the product and type the version you run. It's compared with this record's version ranges in your browser; the version isn't sent anywhere.

VendorProduct
ciscoadvanced malware protection for endpoints
microsoftwindows

Affected versions

NVD version ranges (for catalog products). Add the product to your stack with a version and matching uses these.

  • cisco advanced malware protection for endpoints6.2(3)

Versions reported by the vendor

Affected version ranges reported by the assigning authority (cisco). Independent of NVD's CPE analysis and usually ahead of it.

  • Cisco Cisco AMP for Endpoints

    • unspecified and later · before 6.3.3affected

Same product

cisco: all records

Other highest-scoring records for the same primary product.

  • CVE-2021-1386Cisco Advanced Malware Protection for Endpoints Windows Connector, ClamAV for Windows, and Immunet DLL Hijacking Vulnerability
    31Monitor
  • CVE-2021-1280Cisco Advanced Malware Protection for Endpoints and Immunet for Windows DLL Hijacking Vulnerability
    29Monitor
  • CVE-2018-15452Cisco Advanced Malware Protection for Endpoints on Windows DLL Preloading Vulnerability
    26Monitor
  • CVE-2017-12312An untrusted search path (aka DLL Preloading) vulnerability in the Cisco Immunet antimalware installer could allow an authenticated, local a
    26Monitor
  • CVE-2020-3350Cisco AMP for Endpoints and ClamAV Privilege Escalation Vulnerability
    25Monitor
  • CVE-2020-3314Cisco AMP for Endpoints Mac Connector Software File Scan Denial of Service Vulnerability
    24Monitor

Remediation

Which version to upgrade to

Fix versions compiled from the vendor, package registries and Microsoft. Verify the vendor's note before upgrading.

No fix version is recorded for this entry. Check the references for vendor advisories.

Exploit status

No known public exploit

No public exploit has been observed yet. That doesn't mean you're safe, only that the bar is a little higher.

Research context

For pentesters and researchers: attack profile, score disagreement, timeline, patch commits, credits, variant and chain candidates, bug bounty scope. All derived from existing data; no exploit code.

Timeline

From publication to today: proof of concept, Metasploit module, CISA KEV and fix record. Dates are as reported by the sources.

No dated events beyond publication.

EPSS, last 120 days

FIRST EPSS daily score; only changes of 0.01 or more are recorded (step chart).

Patch and commit links

Commit, PR and diff links among the references. A starting point for patch-diffing and variant hunting; fixes, not exploits.

No commit or PR link among the references.

Credits

All researchers

Finders, reporters and analysts named in the CNA record. Click a name for that researcher’s other records.

No credits in the CNA record.

Variant candidates

Same product, same weakness class, within 18 months. If the patch missed the root cause, the sibling bug is here.

No nightly-computed relations.

Chain candidates

An authentication bypass and a privilege-requiring bug in the same product, published close together: combined they may become an unauthenticated path.

—

Bug bounty scope

No known public program.

Source: bounty-targets-data (public HackerOne, Bugcrowd, Intigriti, YesWeHack listings).

Technical details

Attack conditions

  • Someone with local access to the system can trigger it.
  • Administrator privileges are required.
  • No user action is required.
  • No special conditions are required; it is repeatable.

If successful

Confidentiality
high · data can be read
Integrity
high · data or configuration can be modified
Availability
high · the service can be disrupted
Attack vector
Local
Attack complexity
Low
Privileges required
High
User interaction
None
Scope
Unchanged
Confidentiality impact
High
Integrity impact
High
Availability impact
High

Weakness class (CWE)

CWE-345 · Insufficient Verification of Data Authenticity

CVSS vector

CVSS:3.0/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

nvd-primary

Attack context

MITRE CAPEC attack patterns and ATT&CK techniques for this weakness class (CWE). A starting point for detection rules and threat hunting.

Change log

No changes recorded on tracked fields yet. Score, KEV, exploit maturity and fix status changes appear here.

References

Vendor advisories and official records. Exploit/PoC links are deliberately left out.

All records